Literature DB >> 21649444

Synthesis of amphiphilic alternating polyesters with oligo(ethylene glycol) side chains and potential use for sustained release drug delivery.

Wei Wang1, Jianxun Ding, Chunsheng Xiao, Zhaohui Tang, Di Li, Jie Chen, Xiuli Zhuang, Xuesi Chen.   

Abstract

Novel amphiphilic alternating polyesters, poly((N-phthaloyl-l-glutamic anhydride)-co-(2-(2-(2-methoxyethoxy)ethoxy)methyl)oxirane) (P(PGA-co-ME(2)MO)), were synthesized by alternating copolymerization of PGA and ME(2)MO. The structures of the synthesized polyesters were characterized by (1)H NMR, (13)C NMR, FT-IR, and GPC analyses. Because of the presence of oligo(ethylene glycol) (OEG) side chains, the polyesters could self-assemble into thermosensitive micelles. Dynamic light scattering (DLS) showed that these micelles underwent thermoinduced size decrease without intermicellar aggregation. In vitro methyl thiazolyl tetrazolium (MTT) assay demonstrated that the polyesters were biocompatible to Henrietta Lacks (HeLa) cells, rendering their potential for drug delivery applications. Two hydrophobic drugs, rifampin and doxorubicin (DOX), were loaded into the polyester micelles and observed to be released in a zero-order sustained manner. The sustained release could be accelerated in lower pH or in the presence of proteinase K, due to the degradation of the polyester under these conditions. Remarkably, in vitro cell experiments showed that the polyester micelles accomplished fast release of DOX inside cells and higher anticancer efficacy as compared with the free DOX. With enhanced stability during circulation condition and accelerated drug release at the target sites (e.g., low pH or enzyme presence), these novel polyesters with amphiphilic structures are promising to be used in sustained release drug delivery systems.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21649444     DOI: 10.1021/bm200668n

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  8 in total

1.  Cationic Amphiphilic Alternating Copolymers with Tunable Morphology.

Authors:  Jingling Zhang; Xiaoxi Yu; Bingqian Zheng; Jiachun Shen; Surita R Bhatia; Nicole S Sampson
Journal:  Polym Chem       Date:  2020-07-29       Impact factor: 5.582

2.  Synthesis of water-soluble poly(α-hydroxy acids) from living ring-opening polymerization of O-benzyl-L-serine carboxyanhydrides.

Authors:  Yanbing Lu; Lichen Yin; Yanfeng Zhang; Zhang Zhonghai; Yunxiang Xu; Rong Tong; Jianjun Cheng
Journal:  ACS Macro Lett       Date:  2012-04-17       Impact factor: 6.903

Review 3.  Multi-stimuli responsive macromolecules and their assemblies.

Authors:  Jiaming Zhuang; Mallory R Gordon; Judy Ventura; Longyu Li; S Thayumanavan
Journal:  Chem Soc Rev       Date:  2013-06-13       Impact factor: 54.564

4.  In vitro evaluation of anticancer nanomedicines based on doxorubicin and amphiphilic Y-shaped copolymers.

Authors:  Di Li; Jian Xun Ding; Zhao Hui Tang; Hai Sun; Xiu Li Zhuang; Jing Zhe Xu; Xue Si Chen
Journal:  Int J Nanomedicine       Date:  2012-05-31

5.  Engineering of a New Bisphosphonate Monomer and Nanoparticles of Narrow Size Distribution for Antibacterial Applications.

Authors:  Nimrod Tal; Safra Rudnick-Glick; Igor Grinberg; Michal Natan; Ehud Banin; Shlomo Margel
Journal:  ACS Omega       Date:  2018-02-02

Review 6.  Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19.

Authors:  M Abd Elkodous; S O Olojede; Mahmoud Morsi; Gharieb S El-Sayyad
Journal:  RSC Adv       Date:  2021-08-02       Impact factor: 4.036

Review 7.  Injectable Hydrogel-Based Nanocomposites for Cardiovascular Diseases.

Authors:  Xiaoshan Liao; Xushan Yang; Hong Deng; Yuting Hao; Lianzhi Mao; Rongjun Zhang; Wenzhen Liao; Miaomiao Yuan
Journal:  Front Bioeng Biotechnol       Date:  2020-03-31

Review 8.  Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases.

Authors:  Yudi Deng; Xudong Zhang; Haibin Shen; Qiangnan He; Zijian Wu; Wenzhen Liao; Miaomiao Yuan
Journal:  Front Bioeng Biotechnol       Date:  2020-01-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.